Evencaleucel

N/A

Report date: 2024/01/17 09:19:01

Base Information

Drug NameEvencaleucel
Drug Alias NameNatural killer cell therapy (CellProtect Nordic Pharmaceuticals)CellProtectACP-001
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellprotect Nordic PharmaceuticalsXNK Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesKarolinska InstitutetXNK Therapeutics AB
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A